Vikrant Pharmaceuticals Limited

Pharmaceutical company manufacturing and exporting various formulations from Maharashtra.

1984 | Mumbai, Maharashtra (India) | Active
Last Updated:

Vikrant Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 6.00 Cr
  • Paid Up Capital ₹ 2.24 Cr
  • Company Age 41 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 5.01 Cr
  • Satisfied Charges ₹ 2.67 M
  • Revenue Growth %
  • Profit Growth -223.38%
  • Ebitda -241.91%
  • Net Worth -0.90%
  • Total Assets -0.92%

About Vikrant Pharmaceuticals

Vikrant Pharmaceuticals Limited (VPL) is a Public Limited Indian Non-Government Company incorporated in India on 16 February 1984 and has a history of 41 years and one month. Its registered office is in Mumbai, Maharashtra, India.

The Corporate was formerly known as Vikrant Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 2.24 Cr.

The company currently has active open charges totaling ₹5.01 Cr. The company has closed loans amounting to ₹2.67 M, as per Ministry of Corporate Affairs (MCA) records.

Shruti Ladhani, Kamala Vastupal, and Vastupal Pratapchand serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U99999MH1984PLC032190

  • Company No.

    032190

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    16 Feb 1984

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Vikrant Pharmaceuticals Limited offer?

Vikrant Pharmaceuticals Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, TB, Tumor & Cancer Drugs, Anti Cancer Injection, Anti Cancer Medicines, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Arthritic Drugs, Steroid, Brain & Nervous System Drugs.

Who are the key members and board of directors at Vikrant Pharmaceuticals?

Executive Team (1)

NameDesignationAppointment DateStatus
Vastupal Pratapchand Country flag representing In Managing Director17-Feb-1984Current

Board Members (2)

NameDesignationAppointment DateStatus
Shruti Ladhani Country flag representing In Director 27-Dec-2016Current
Kamala Vastupal Country flag representing In Whole-Time Director 15-Mar-1984Current

Financial Performance of Vikrant Pharmaceuticals.

Vikrant Pharmaceuticals Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 223.38% decrease in profit. The company's net worth dipped by a decrease of 0.9%.

Vikrant Pharmaceuticals revenue growth over time
Vikrant Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-0.92%
Profit or Loss
-223.38%
Net Worth
-0.90%
EBITDA
-241.91%

What is the Ownership and Shareholding Structure of Vikrant Pharmaceuticals?

In 2020, Vikrant Pharmaceuticals had a promoter holding of 16.92% and a public holding of 83.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹5.01 Cr

Satisfied Charges

₹0.27 Cr

Charges Breakdown by Lending Institutions

  • Bank Of India : 5.00 Cr
  • Citibank Na : 0.01 Cr

Latest Charge Details

DateLenderAmountStatus
29 Nov 2014Bank Of India₹5.00 CrOpen
20 Feb 1988Citibank Na₹0.06 MOpen
05 Jun 2010Syndicate Bank₹0.50 MSatisfied
15 Sep 1987New Bank Of India₹0.20 MSatisfied
21 Aug 1985New Bank Of India₹0.40 MSatisfied

How Many Employees Work at Vikrant Pharmaceuticals?

Unlock and access historical data on people associated with Vikrant Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Vikrant Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vikrant Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vikrant Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Vikrant Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Vikrant Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Vikrant Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Director Appointment

    Shruti Neeraj Ladhani was appointed as a Director was appointed as a Director on 27 Dec 2016 & has been associated with this company since 8 years 3 months .

  • Charges

    A charge with Bank Of India amounted to Rs. 5.00 Cr with Charge ID 10542702 was registered on 29 Nov 2014.

  • Charges

    A charge registered on 05 Jun 2010 via Charge ID 10229637 with Syndicate Bank was fully satisfied on 18 Apr 2012.

  • Charges

    A charge with Syndicate Bank amounted to Rs. 0.05 Cr with Charge ID 10229637 was registered on 05 Jun 2010.

Frequently asked questions

  • What is the Incorporation or founding date of Vikrant Pharmaceuticals Limited?

    Vikrant Pharmaceuticals Limited was incorporated on 16 Feb 1984.

  • What is authorized share capital and paid-up capital of Vikrant Pharmaceuticals Limited?

    The authorized share capital of Vikrant Pharmaceuticals Limited is ₹ 6.00 Cr and paid-up capital is ₹ 2.24 Cr.

  • Who are the current board members & directors of Vikrant Pharmaceuticals Limited?

    Currently 3 directors are associated with Vikrant Pharmaceuticals Limited.

    • Shruti Neeraj Ladhani
    • Kamala Ladhani Vastupal
    • Vastupal Ladhani Pratapchand

  • What is the registered address of Vikrant Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Vikrant Pharmaceuticals Limited is Govind Nivas 1St Floor 62/64, Dhanji Street India, Mumbai, Maharashtra, 400003.

  • What is the corporate identification number (CIN) and company number of Vikrant Pharmaceuticals Limited?

    The corporate identification number (CIN) of Vikrant Pharmaceuticals Limited is U99999MH1984PLC032190 and the company number is 032190 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Vikrant Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Vikrant Pharmaceuticals Limited has experienced an downturn of -0.90%.

  • What are the total open charges for Vikrant Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2022, The total open charges for Vikrant Pharmaceuticals Limited amount to ₹ 5.01 Cr.

  • When was the last Balance Sheet of Vikrant Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Vikrant Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

People also Viewed